Amidst all of the doom and gloom of patent clifts, global economic crises, falling medicare reimbursement rates, and until recently, low FDA approval rates, I found this interview with the CEO of Lilly to be uplifting. Good to be reminded of the potential of biomedical research, and good to hear a positive message from an industry CEO?
http://online.wsj.com/article/SB10001424052970203611404577042813309766648.html
Sent from Read It Later - Get it free!
Sent from Read It Later - Get it free!
